Replies to post #177951 on Biotech Values

[~S.B.A.~]

$RTGN moving up big time. Direct beneficiary to antibiotic resistance crisis presented by W.H.O. 2.5million share float w/ $20million in cash. Rounding bottom signaling major reversal

[indigokid]

How does FDA orphan drug designation for a specific small market indication, in this case "non-infectious uveitis" (now with new 7 year marketing protection), affect the approval/launch of a potential generic and/or more likely a potential "interchangeable" generic on a blockbuster drug like Humira with lots of indications and a patent expiration of 12/2016?

[DewDiligence]

Humira receives another FDA orphan-drug designation—this time for hidradenitis suppurativa:

http://finance.yahoo.com/news/abbvie-receives-orphan-drug-designation-134400655.html